Connect to other sites within the UBM Medica Network
SGLT2 Inhibitors: Basic Training Quiz
The sodium glucose cotransporter-2 inhibitors are the newest diabetes drugs available. Have you got the basic concepts under your belt? Try these 6 questions and find out.
Danish Study Suggests Cardioprotective Effects of GLP-1 Agonist and Insulin
Evidence to date is conflicting on the potential role of antihyperglycemic drugs, old and new, in cardioprotection. Results reported here add to the pool and fuel ongoing study.
Why Not Prescribe a SGLT2 Inhibitor for this Patient?
The sodium glucose cotransporter-2 inhibitors have many advantages eg, modest A1c reduction and low hypoglycemia risk. But careful patient selection is critical.
Widespread "Yellow Bumps"
A woman with poorly controlled type 2 diabetes presented with widespread “yellow bumps" of sudden onset. What's your diagnosis?
Menopause in Women with Diabetes: Hormonal-glycemic Storm
For nondiabetic women, menopause is an extended biological and physiological purgatory. For those with type 1 or type 2 diabetes, it's worse.
Obesity Predicts Response to Treatment Intensification with Biphasic Insulin 50/50
A recent study identifies a sweet spot for use of premixed biphasic insulin 50/50 in routine clinical practice.
Slower Eating Increases Satiety, Reduces Hunger in Type 2 Diabetes Patients
Faulty brain satiety centers and impaired gut hormone function are risk factors for weight gain in patients with type 2 diabetes. A recent study suggests one simple antidote: Slow down.
Earn CME Credits for reading Psychiatric Times articles. Click here to go to our free online CME activities.
By clicking Accept, you agree to become a member of the UBM Medica Community.